Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Use of ACOTEC Drug-Eluting Balloon Litos ® in Below-The-Knee Arteries to Treat Critical Limb Ischemia (ACOART-BTK)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02563535
Recruitment Status : Unknown
Verified September 2015 by Leonardo Bolognese, MD, Ospedale San Donato.
Recruitment status was:  Recruiting
First Posted : September 30, 2015
Last Update Posted : September 30, 2015
Sponsor:
Information provided by (Responsible Party):
Leonardo Bolognese, MD, Ospedale San Donato

Brief Summary:
The aim of this study is to evaluate the potential advantage in terms of late lumen loss reduction of Litos drug-eluting balloon vs standard percutaneous transluminal angioplasty in the treatment of below-the-knee disease in patients with critical limb ischemia.

Condition or disease Intervention/treatment Phase
Peripheral Artery Disease Device: DEB Device: PTA Phase 4

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 140 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Study Start Date : September 2015
Estimated Primary Completion Date : December 2016
Estimated Study Completion Date : December 2018

Arm Intervention/treatment
Experimental: Drug-eluting balloon
angioplasty with Litos drug-eluting balloon
Device: DEB
angioplasty with Litos drug eluting balloon

Active Comparator: conventional PTA
angioplasty with conventional balloon
Device: PTA
angioplasty with conventional balloon




Primary Outcome Measures :
  1. Late Lumen Loss (LLL) in the target lesion documented by angiography [ Time Frame: 6 months ]
    Late Lumen Loss (LLL) in the target lesion documented by angiography


Secondary Outcome Measures :
  1. Number of events of angiographic binary restenosis [ Time Frame: 12 months ]
    number of events of angiographic binary restenosis

  2. Number of events of target lesion revascularization (TLR) [ Time Frame: 12 months ]
    number of events of target lesion revascularization



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age>18 years
  • critical limb ischemia (Rutherford class 4-6)
  • angiographic stenosis>50% or occlusion of at least one tibial vessel of at least 40mm for which an interventional treatment is scheduled

Exclusion Criteria:

  • need for major amputation known before intervention
  • allergy to Paclitaxel
  • contraindication for combined antiplatelet treatment
  • life expectancy <1 year
  • hypersensitivity or contraindication to one of the study drugs
  • lack of consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02563535


Locations
Layout table for location information
Italy
Cardiovascular Department, Ospedale S.Donato Recruiting
Arezzo, AR, Italy, 52100
Contact: Francesco Liistro, MD       francescoliistro@hotmail.com   
Principal Investigator: Leonardo Bolognese, MD, FESC         
Sub-Investigator: Giovanni Falsini, MD         
Sub-Investigator: Paolo Angioli, MD         
Sub-Investigator: Kenneth Ducci, MD         
Principal Investigator: Francesco Liistro, MD         
Sub-Investigator: Simone Grotti, MD         
Sponsors and Collaborators
Ospedale San Donato

Layout table for additonal information
Responsible Party: Leonardo Bolognese, MD, MD, Ospedale San Donato
ClinicalTrials.gov Identifier: NCT02563535     History of Changes
Other Study ID Numbers: Arezzo015
First Posted: September 30, 2015    Key Record Dates
Last Update Posted: September 30, 2015
Last Verified: September 2015
Additional relevant MeSH terms:
Layout table for MeSH terms
Peripheral Arterial Disease
Atherosclerosis
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases
Peripheral Vascular Diseases